Table 5. Comparison of saliva with other body fluids / tissue for measurement of various analytes in selected pathological conditions.
| Conditions | Comparison carried out | Markers / analytes | Correlations observed | Remarks | Reference |
|---|---|---|---|---|---|
| Head and neck cancer |
Saliva – tumor tissue |
Mitochondrial DNA |
Positive |
Increased levels that decreased in post-surgical condition |
(47) |
| OSCC |
Saliva-serum |
p53 antibody |
Positive |
Saliva may offer a specific method for detection of a subset of OSCC with p53 aberrations |
(48) |
| Malignant ovarian tumors |
Saliva-serum |
CA 125 |
Positive |
Saliva assay showed better assay value than serum |
(63) |
| Breast cancer |
Saliva-serum |
Cellular erythroblastosis oncogene B-2 (c-erbB-2) |
Positive |
ErbB-2 protein may have potential use in the initial detection and/or follow-up screening of breast cancer in women |
(3) |
| Dengue |
Saliva-serum |
Dengue antibody |
Positive |
Saliva as an alternative for dengue diagnosis |
(50) |
| Sjögren’s syndrome |
Saliva- serum |
C-X-C motif chemokine 13 |
Positive |
CXCL13 may provide an innovative approach for managing this disease |
(3) |
| HIV | Saliva-serum | HIV antibody | Positive | Formulation of a commercially available diagnostic kit OraQuick | (63) |
EGF - epidermal growth factor; HIV - human immuno deficiency virus.